¼¼°èÀÇ ¾ó±¼¿ë ÁÖ»çÁ¦ ½ÃÀå
Facial Injectables
»óǰÄÚµå : 1760872
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 194 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,106,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,320,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¾ó±¼¿ë ÁÖ»çÁ¦ ¼¼°è ½ÃÀåÀº 2030³â±îÁö 288¾ï ´Þ·¯¿¡ À̸¦ Àü¸Á

2024³â¿¡ 193¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ¾ó±¼¿ë ÁÖ»çÁ¦ ¼¼°è ½ÃÀåÀº 2024-2030³â ºÐ¼® ±â°£¿¡ CAGR 6.9%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 288¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. º» º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ AÇü º¸Åø¸®´®Åå½Å(º¸Å彺)´Â CAGR6.8%¸¦ ³ªÅ¸³»°í, ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 160¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. È÷¾Ë·ç·Ð»ê(HA) ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£Áß CAGR 7.6%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 50¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ÇÑÆí, Áß±¹Àº CAGR 11.3%¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµÈ´Ù

¹Ì±¹ÀÇ ¾ó±¼¿ë ÁÖ»çÁ¦ ½ÃÀåÀº 2024³â¿¡ 50¾ï ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 71¾ï ´Þ·¯ ±Ô¸ð¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGRÀº 11.3%·Î ¿¹»óµË´Ï´Ù. ±âŸ ÁÖ¸ñÇØ¾ß ÇÒ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£Áß CAGRÀº °¢°¢ 2.9%¿Í 6.8%¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 3.6%¸¦ º¸ÀÏ Àü¸ÁÀÔ´Ï´Ù.

¼¼°èÀÇ ¾ó±¼¿ë ÁÖ»çÁ¦ ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

¾ó±¼ Áֻ簡 ¿¡½ºÅׯ½ ¾÷°è¸¦ ÈÛ¾µ°í ÀÖ´Â ÀÌÀ¯´Â ¹«¾ùÀϱî?

ÇǺΠÇÊ·¯¿Í º¸Å彺¿Í °°Àº ½Å°æµ¶À» ÇÔÀ¯ÇÑ ¾ó±¼ ÁÖ»ç´Â ÃÖ¼Ò Ä§½ÀÀûÀÌ°í ºü¸£°Ô ´«¿¡ ¶ç´Â È¿°ú·Î ÀÎÇØ È­Àåǰ »ê¾÷ÀÇ ÇÙ½ÉÀÌ µÇ¾ú½À´Ï´Ù. ÀÌ Á¦Ç°µéÀº ÁÖ¸§À» ÁÙÀ̰í, ¾ó±¼ À±°ûÀ» °­Á¶Çϰí, ºÎÇÇ °¨¼Ò¸¦ ȸº¹ÇÏ´Â µ¥ »ç¿ëµÇ¸ç, ¼ö¼ú ¾øÀ̵µ Àþ¾î º¸ÀÌ´Â È¿°ú¸¦ Á¦°øÇÕ´Ï´Ù. ¾ó±¼ ÁÖ»çÀÇ Àαâ´Â ȸº¹ÀÌ ºü¸£°í È¿°ú°¡ ¿À·¡ Áö¼ÓµÇ´Â ºñ¼ö¼úÀû ¹Ì¿ë ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ÒºñÀÚ ¼ö¿ä Áõ°¡·Î ÀÎÇØ ±ÞÁõÇϰí ÀÖ½À´Ï´Ù. Àü ¼¼°è Ŭ¸®´Ð°ú ¿¡½ºÅׯ½ ¼¾ÅÍ¿¡¼­´Â À£ºù°ú ¼¿ÇÁ Äɾ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ °³Àο¡°Ô ¸Â´Â ¹Ì¿ë ½Ã¼úÀ» ¿øÇÏ´Â »ç¶÷µéÀÌ ´Ã¾î³ª¸é¼­ ½Ã¼ú °Ç¼ö°¡ ²ÙÁØÈ÷ Áõ°¡Çϰí ÀÖ´Â °ÍÀ¸·Î º¸°íµÇ°í ÀÖ½À´Ï´Ù.

¾î¶² ±â¼ú Çõ½ÅÀÌ ¾ó±¼¿¡ ÁÖÀÔ Ä¡·á¸¦ °­È­Çϰí Àִ°¡?

±â¼úÀÇ ¹ßÀüÀº ¾ó±¼ ÁÖ»ç ½ÃÀå¿¡ Å« ¿µÇâÀ» ¹ÌÄ¡°í ÀÖÀ¸¸ç, º¸´Ù Á¤±³ÇÑ Á¦Ç° ¹× ÀÀ¿ë ±â¼úÀÇ °³¹ß·Î À̾îÁö°í ÀÖ½À´Ï´Ù. »õ·Î¿î Á¦ÇüÀº ´õ ¿À·¡ Áö¼ÓµÇ°í, ´õ ÀÚ¿¬½º·¯¿î °á°ú¸¦ Á¦°øÇϸç, º×±â³ª ºÒÆíÇÔ°ú °°Àº ºÎÀÛ¿ëÀ» ÁÙÀ̵µ·Ï ¼³°èµÇ¾ú½À´Ï´Ù. È÷¾Ë·ç·Ð»ê ±â¹Ý ÇÊ·¯¿Í °°Àº Çõ½ÅÀûÀÎ Á¦Ç°Àº ÇǺο¡ Áï°¢ÀûÀÎ º¼·ý°ú ¼öºÐÀ» °ø±ÞÇÏ¿© Á¡Á¡ ´õ Àα⸦ ¾ò°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¹Ù´ÃÀ» »ç¿ëÇÏÁö ¾Ê´Â ÁÖ»ç±â³ª ¸¶ÀÌÅ©·Î´Ïµé¸µ ÀåÄ¡ÀÇ µµÀÔÀº ÀÌ·¯ÇÑ Ä¡·á¹ý¿¡ Çõ¸íÀ» ÀÏÀ¸ÄÑ È¯Àڵ鿡°Ô º¸´Ù ¾ÈÀüÇÏ°í Æí¾ÈÇÑ Ä¡·á¸¦ Á¦°øÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú Çõ½ÅÀº ȯÀÚÀÇ ¸¸Á·µµ¸¦ Çâ»ó½Ãų »Ó¸¸ ¾Æ´Ï¶ó ¹Ì¿ë Àü¹®°¡ÀÇ È¿À²¼º°ú Á¤È®¼ºÀ» Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù.

¼ÒºñÀÚ ÇൿÀº ¾î¶»°Ô ¾ó±¼ ÁÖ»ç ½ÃÀåÀ» Çü¼ºÇϰí Àִ°¡?

¼ÒºñÀÚ ÇൿÀº ¾ó±¼ ÁÖ»ç ½ÃÀå Çü¼º¿¡ ÀÖ¾î ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ÇǺΠ°Ç°­À» À¯ÁöÇÏ°í ³ëÈ­ ÁøÇàÀ» ´ÊÃß±â À§ÇÑ Ä¡·á¸¦ ¿øÇÏ´Â ÀþÀº ÃþÀÇ '¿¹¹æ ¹Ì¿ë' Æ®·»µå°¡ ºü¸£°Ô È®´ëµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¼Ò¼È ¹Ìµð¾î¿Í ¼¿·¯ºê¸®Æ¼ ¹®È­ÀÇ ¿µÇâÀ¸·Î ÀÎÅͳݿ¡¼­ º¼ ¼ö ÀÖ´Â ¿Ïº®Çϰí Àþ¾î º¸ÀÌ´Â ¿Ü¸ð¸¦ Ãß±¸ÇÏ´Â »ç¶÷µéÀÌ ´Ã¾î³ª¸é¼­ ¹Ì¿ë °­È­¿¡ ´ëÇÑ ¿å±¸°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ º¯È­´Â ¿©·¯ Á¦Ç°À» º´¿ëÇÏ°í ¾ó±¼ÀÇ Æ¯Á¤ ºÎÀ§¸¦ Ÿ°ÙÀ¸·Î ÇÏ¿© ȯÀÚ°¡ °¢ÀÚÀÇ ¹ÌÀû ¸ñÇ¥¿¡ ¸Â´Â ¼Ö·ç¼ÇÀ» ¹ÞÀ» ¼ö ÀÖµµ·Ï ÇÏ´Â °³Àκ° ¸ÂÃã Ä¡·á ¹× º´¿ë Ä¡·áÀÇ ºÎ»óÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¿©¼º»Ó¸¸ ¾Æ´Ï¶ó ³²¼ºµé »çÀÌ¿¡¼­µµ ¹Ì¿ë ¼ºÇüÀÌ ¹Þ¾Æµé¿©Áö°í ÀÏ»óÈ­µÇ°í ÀÖ´Â °Íµµ ÀÌ ½ÃÀåÀÇ Àα¸ÃþÀ» È®´ëÇϰí ÀÖ½À´Ï´Ù.

¾ó±¼ ÁÖ»ç ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ¿äÀÎÀº ¹«¾ùÀΰ¡?

¾ó±¼ ÁÖ»ç ½ÃÀåÀÇ ¼ºÀåÀº ´Ù¿îŸÀÓÀÌ Àû°í ÀÚ¿¬½º·¯¿î °á°ú¸¦ Á¦°øÇÏ´Â ºñħ½ÀÀû ¹Ì¿ë ½Ã¼ú¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡ µî ¸î °¡Áö ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ¼Ò¼È ¹Ìµð¾îÀÇ ¿µÇâ°ú ÀþÀº Ãþ¿¡¼­ ¿¹¹æÀû ÇǺΠ°ü¸®ÀÇ ÀαⰡ ³ô¾ÆÁü¿¡ µû¶ó ½ÃÀåÀÌ ´õ¿í ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. ´õ ¿À·¡ Áö¼ÓµÇ°í ¾ÈÀüÇÑ Á¦ÇüÀÇ °³¹ß°ú °°Àº ±â¼ú ¹ßÀüÀº ½Å·ÚÇÒ ¼ö ÀÖ°í È¿°úÀûÀÎ Ä¡·á¹ýÀ» ã´Â °í°´µéÀ» ²ø¾îµéÀ̰í ÀÖ½À´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾ç µî¿¡¼­´Â °æÀï»ç ´ëºñ Àú·ÅÇÑ °¡°ÝÀ¸·Î ½Ã¼úÀ» ¹ÞÀ» ¼ö ÀÖ´Â ÀÇ·á °ü±¤ÀÇ ºÎ»óµµ ¾ó±¼ ÁÖ»ç ½ÃÀåÀÇ ¼¼°è Àúº¯À» ³ÐÈ÷°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ³²¼ºµé »çÀÌ¿¡¼­µµ ¹Ì¿ë ¼ºÇü¿¡ ´ëÇÑ ÀνÄÀÌ °³¼±µÇ°í ÀÖÀ¸¸ç, °³Àκ° ¸ÂÃã Ä¡·á ÆÐŰÁö¸¦ ÀÌ¿ëÇÒ ¼ö ÀÖ°Ô µÊ¿¡ µû¶ó ¾÷°è¿¡ »õ·Î¿î ¼ºÀå ±âȸ°¡ âÃâµÇ°í ÀÖ½À´Ï´Ù.

ºÎ¹®

Á¦Ç° À¯Çü(AÇü º¸Åø¸®´®Åå½Å(º¸Å彺), È÷¾Ë·ç·Ð»ê(HA), Æú¸®¸Ó ÇÊ·¯, Äݶó°Õ, ¼ö»ê ¾îÆÛŸÀÌÆ® Ä®½·(CaHA)), ÃÖÁ¾ ¿ëµµ(¹Ì¿ë, Ä¡·á), ÃÖÁ¾»ç¿ëÀÚ(ÇǺΰú Ŭ¸®´Ð, º´¿ø, ±âŸ ÃÖÁ¾»ç¿ëÀÚ)

Á¶»ç ´ë»ó ±â¾÷ ¿¹(ÃÑ 41°³»ç)

AI ÅëÇÕ

Global Industry Analysts´Â À¯È¿ÇÑ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AIÅø¿¡ ÀÇÇØ¼­, ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ º¯ÇõÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â ÀϹÝÀûÀÎ LLM³ª ¾÷°èº° SLM Äõ¸®¿¡ µû¸£´Â ´ë½Å¿¡, ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ´ë·® ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî, Àü ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»çÀÇ ±¹°¡, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±â¹ÝÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇß½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¼öÀÍ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº °¨¼Ò, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû ¹× °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Facial Injectables Market to Reach US$28.8 Billion by 2030

The global market for Facial Injectables estimated at US$19.3 Billion in the year 2024, is expected to reach US$28.8 Billion by 2030, growing at a CAGR of 6.9% over the analysis period 2024-2030. Botulinum Toxin Type A, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$16.0 Billion by the end of the analysis period. Growth in the Hyaluronic Acid (HA) segment is estimated at 7.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$5.0 Billion While China is Forecast to Grow at 11.3% CAGR

The Facial Injectables market in the U.S. is estimated at US$5.0 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$7.1 Billion by the year 2030 trailing a CAGR of 11.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.9% and 6.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.6% CAGR.

Global Facial Injectables Market - Key Trends & Drivers Summarized

Why Are Facial Injectables Dominating the Aesthetic Industry?

Facial injectables, including dermal fillers and neurotoxins like Botox, have become a cornerstone in the cosmetic industry due to their minimally invasive nature and quick, visible results. These products are used to reduce wrinkles, enhance facial contours, and restore volume loss, providing a youthful appearance without the need for surgery. The popularity of facial injectables has surged, driven by increasing consumer demand for non-surgical aesthetic solutions that offer quick recovery times and long-lasting effects. Clinics and aesthetic centers around the world are reporting a steady increase in the number of procedures, as individuals seek personalized cosmetic treatments that align with the growing emphasis on wellness and self-care.

What Technological Innovations Are Enhancing Facial Injectable Treatments?

Technological advancements are significantly influencing the facial injectables market, leading to the development of more refined products and application techniques. New formulations are being designed to last longer, offer more natural-looking results, and reduce side effects such as swelling or discomfort. Innovations like hyaluronic acid-based fillers, which provide immediate volume and hydration to the skin, are becoming increasingly popular. Additionally, the introduction of needle-free injectors and micro-needling devices is revolutionizing the delivery of these treatments, making procedures safer and more comfortable for patients. These innovations not only improve patient satisfaction but also enhance the efficiency and precision of cosmetic professionals.

How Is Consumer Behavior Shaping the Facial Injectables Market?

Consumer behavior is playing a pivotal role in shaping the facial injectables market. The trend of "preventative aesthetics," where younger individuals seek treatments to maintain skin health and delay the onset of aging, is growing rapidly. Moreover, the influence of social media and celebrity culture is driving the desire for cosmetic enhancement, as people increasingly seek to achieve the flawless and youthful looks seen online. This shift is also promoting the rise of personalized and combination treatments, where multiple products are used together to target specific facial areas, ensuring that patients receive tailored solutions for their aesthetic goals. The growing acceptance and normalization of cosmetic procedures among both women and men are also expanding the market’s demographic reach.

What Factors Are Fueling the Growth of the Facial Injectables Market?

The growth in the facial injectables market is driven by several factors, including the increasing demand for non-invasive aesthetic procedures that offer minimal downtime and natural-looking results. The influence of social media and the growing popularity of preventative skincare among younger demographics are further boosting the market. Technological advancements, such as the development of longer-lasting and safer formulations, are attracting more customers looking for reliable and effective treatments. The rise of medical tourism in regions like Asia-Pacific, where procedures are offered at competitive prices, is also expanding the global reach of the facial injectables market. Additionally, the increasing acceptance of cosmetic procedures among men and the availability of personalized treatment packages are creating new growth opportunities for the industry.

SCOPE OF STUDY:

The report analyzes the Facial Injectables market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Botulinum Toxin Type A, Hyaluronic Acid (HA), Polymer Fillers, Collagen, Calcium Hydroxylapatite (CaHA)); Application (Aesthetics, Therapeutics); End-Use (Dermatology Clinics, Hospitals, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 41 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â